Merck KGaA (ETR:MRK)
Germany
· Delayed Price · Currency is EUR 145.65
-1.35 (-0.92%)
Jun 26, 2026, 5:36 PM CET
Merck KGaA Employees
Merck KGaA had 59,077 employees as of December 31, 2025. The number of employees increased by 57 or 0.10% compared to the previous year.
Employees
59,077
Change (1Y)
57
Growth (1Y)
0.10%
Revenue / Employee
€354,717
Profits / Employee
€42,861
Market Cap
63.33B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Fresenius SE & Co. KGaA | 177,783 |
| Sartorius Aktiengesellschaft | 14,242 |
| Fresenius Medical Care AG | 108,165 |
| Fielmann Group AG | 18,928 |
| Ottobock SE & Co. KGaA | 10,365 |
| SCHOTT Pharma AG & Co. KGaA | 4,839 |
Merck KGaA News
- 2 days ago - Merck KGaA Transcript: M&A announcement - Transcripts
- 2 days ago - Merck KGaA Slides: M&A announcement - Filings
- 2 days ago - Merck KGaA Press release: M&A announcement - Filings
- 2 days ago - Germany's Merck Is Buying Bio-Techne for $11.3 Billion - Barrons
- 2 days ago - Germany's Merck to buy Bio-Techne for $73 per share - Reuters
- 2 days ago - Germany's Merck to Buy Bio-Techne for $11 Billion - WSJ
- 4 days ago - Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies - Business Wire
- 4 days ago - Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies - Business Wire